Mayne Pharma Group (MYX.AX) Earnings Analysis

Mayne Pharma Group (MYX.AX) next reports earnings on 2026-08-20, consensus EPS -0.2835 AUD. Last quarter (2026-02-22) it missed with EPS -0.15 AUD vs -0.016 AUD est (-837.5%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -2.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MYX.AX next report earnings?

Next earnings date2026-08-20
Consensus EPS estimate-0.2835 AUD
Revenue estimate0.19B

MYX.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-22-0.15 AUD-0.016 AUD-837.5%Miss
2025-02-24-0.323 AUD-0.125 AUD-158.4%Miss
2024-08-23-1.31434 AUD-0.223 AUD-489.4%Miss

Beat rate: 0/3 (0%) over reported quarters with consensus data.

MYX.AX valuation and analyst view

Trailing P/E-2.55
Trailing EPS-1.02442 AUD
Price / book0.63
Dividend yield0.00%
Market cap0.23B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Mayne Pharma Group (MYX.AX)'s next earnings date?

Mayne Pharma Group is next scheduled to report on 2026-08-20, with a consensus EPS estimate of -0.2835 AUD and revenue estimate of 0.19B.

Did MYX.AX beat earnings last quarter?

In its 2026-02-22 report, MYX.AX posted EPS of -0.15 AUD versus a -0.016 AUD estimate — a miss of 837.5%.

What is MYX.AX's earnings track record?

Over the last 3 reported quarters with consensus data, MYX.AX beat estimates 0 times (0%).

What is MYX.AX's current P/E ratio and EPS?

MYX.AX trades at a trailing P/E of -2.55 on trailing EPS of -1.0244218450751938 AUD.

What do analysts rate MYX.AX?

MYX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.